Work

BIIB033, Anti-LINGO-1 Antibody, for Treatment of Relapsing Forms of Multiple Sclerosis: Baseline Data of the Phase 2 SYNERGY Trial (P7.204)

Year: 2015

Type: article

Source: Neurology

DOI: 10.1212/wnl.84.14_supplement.p7.204

Authors: Diego Cadavid, Keith Edwards, Raymond Hupperts, Jelena Drulovic, Krzysztof Selmaj, Robert Naismith, Luigi Maria Grimaldi, Alexey Boiko, Oscar Fernandez, Eli Silber, Howard Rossman, Stefanie Freeman, Yi Chai, Lei Xu

Institutions: Biogen (United States), Beth Israel Deaconess Medical Center, Zuyderland Medisch Centrum, Medical University of Lodz, Washington University in St. Louis, Fondazione Istituto G. Giglio di Cefalù, King's College Hospital, Michigan Institute for Neurological Disorders

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2324349338

FWCI: 1.056

Cites:

Cited by: 4

Related to: 10